EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+18.54%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$2.68B
AUM Growth
+$2.68B
Cap. Flow
+$339M
Cap. Flow %
12.66%
Top 10 Hldgs %
68.02%
Holding
82
New
12
Increased
16
Reduced
6
Closed
10

Top Buys

1
ALEC icon
Alector
ALEC
$75.8M
2
MORF
Morphic Holding, Inc. Common Stock
MORF
$54.6M
3
RLAY icon
Relay Therapeutics
RLAY
$38.7M
4
JANX icon
Janux Therapeutics
JANX
$35.2M
5
RCUS icon
Arcus Biosciences
RCUS
$31.3M

Top Sells

1
ELDN icon
Eledon Pharmaceuticals
ELDN
$11.9M
2
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
$10.5M
3
ACIU icon
AC Immune
ACIU
$7.93M
4
NGNE icon
Neurogene
NGNE
$7.05M
5
LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
$5.01M

Sector Composition

1 Healthcare 98.93%
2 Financials 0.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
OVID icon
26
Ovid Therapeutics
OVID
$94.6M
$23.8M 0.89%
6,082,200
– –
NGNE icon
27
Neurogene
NGNE
$284M
$21.8M 0.81%
2,358,804
-763,900
-24% -$7.05M
ACIU icon
28
AC Immune
ACIU
$227M
$21M 0.78%
2,648,163
-1,000,000
-27% -$7.93M
BCEL
29
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$20.7M 0.77%
2,426,685
– –
CNTA
30
Centessa Pharmaceuticals
CNTA
$2.13B
$16.8M 0.63%
+754,545
New +$16.8M
KDNY
31
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$13.2M 0.49%
931,650
-318,351
-25% -$4.5M
ZNTL icon
32
Zentalis Pharmaceuticals
ZNTL
$123M
$10.6M 0.4%
+200,000
New +$10.6M
CRVS icon
33
Corvus Pharmaceuticals
CRVS
$419M
$9.56M 0.36%
+3,579,377
New +$9.56M
KRON
34
DELISTED
Kronos Bio
KRON
$9.28M 0.35%
387,357
– –
TNGX icon
35
Tango Therapeutics
TNGX
$745M
$9.1M 0.34%
800,000
– –
NUVB.WS icon
36
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$8.97M 0.34%
963,333
– –
KLRS
37
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
$8.82M 0.33%
447,012
– –
CCCC icon
38
C4 Therapeutics
CCCC
$182M
$7.57M 0.28%
200,000
– –
CYCN icon
39
Cyclerion Therapeutics
CYCN
$7.75M
$6.26M 0.23%
1,606,276
– –
VERV
40
DELISTED
Verve Therapeutics
VERV
$6.03M 0.23%
+100,000
New +$6.03M
SYRS
41
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$5.45M 0.2%
1,000,000
– –
JYAC
42
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.97M 0.19%
500,000
– –
ALPN
43
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$4.7M 0.18%
522,635
-218,655
-29% -$1.97M
DYN icon
44
Dyne Therapeutics
DYN
$1.92B
$4.52M 0.17%
215,000
– –
OBIO icon
45
Orchestra BioMed
OBIO
$147M
$4.08M 0.15%
400,000
– –
DNTH icon
46
Dianthus Therapeutics
DNTH
$781M
$3.59M 0.13%
366,867
-189,487
-34% -$1.85M
IGMS
47
DELISTED
IGM Biosciences
IGMS
$3.16M 0.12%
+38,030
New +$3.16M
ODT
48
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$2.9M 0.11%
+831,200
New +$2.9M
NGM
49
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2.83M 0.11%
143,567
– –
FMTX
50
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2.63M 0.1%
+105,638
New +$2.63M
1
2
3 4